Page 681 - Bloomberg

WHO sees 'strong commitment' from Pfizer for cheaper Covid-19 vaccines

Bruce Aylward, WHO senior adviser, said that he saw a "strong commitment" on the part of its CEO Albert Bourla to set prices at levels appropriate to poorer populations

US FDA confirms 94.1% efficacy of Moderna vaccine, says it's safe

Publishes findings ahead of key review, paving the way for a second vaccine

Tech giants risk breakup as EU unveils tougher rules to curb power

Companies like Amazon.com Inc, Apple Inc. or Alphabet Inc.'s Google could face fines of as much as 10 per cent of their revenue

Emerging market ETFs close to erasing pandemic-driven outflows, shows data

US-listed ETFs that invest across developing nations as well as those that target specific countries received $2.17 billion in the week ended December 11

A lucky break? Covid-19 measures seem to have killed the flu season

In New York City, influenza-like illnesses' numbers are running at less than one-third of the recent norm for the first half of December

WTO fishing subsidy talks to miss 2020 deadline as China, India baulk

Negotiators were tasked with eliminating subsidies for illegal, unreported and unregulated fishing and prohibiting certain subsidies that contribute to overcapacity and overfishing

If 2020 wasn't enough, here are StanChart's 8 big market risks in 2021

A pandemic wasn't on too many lists last year, but global markets have largely recovered from the shock, helped by emergency fiscal- and monetary action

Without clearing new farmland, two Earths' worth of people can be fed

By 2050-the year when a growing list of nations aim to have zeroed out their contributions to climate change-the UN projects the global population will be 9.7 billion

Singapore to open new lane for business travelers, house them in bubble

Applications for the new travel lane will open next month. People from all countries can apply but must adhere to the travel lane's strict health and testing protocols

Why a torrent of foreign funds threatens India's tight grip on the rupee

There's growing consensus among traders and fund managers that the mounting pressures -- particularly the liquidity glut distorting money markets -- may spur the central bank to consider changes

India is the world's best market for portfolio disclosure, finds study

The report covering 26 markets across North America, Europe, Asia and Africa singled out Australia as a notable laggard

Amazon's Zoox unveils 'Robotaxi' for future ride-hailing service

The vehicle, which Zoox describes as a driverless carriage or robotaxi, can carry as many as four passengers

From being held to ransom to rivalling Ambani's fortunes: Adani's journey

Shares of most of his firms have surged, including those of his mining, gas and ports units

Small-cap stocks may continue to beat large-caps next year in India

The Nifty Midcap 100 Index has climbed 20 per cent this year, and the Nifty Smallcap 100 Index has advanced 17 per cent, outpacing the 11 per cent gain in the large-cap NSE Nifty 50 Index

Premier of last African monarchy is first world leader to die of Covid

Eswatini Prime Minister Ambrose Dlamini was 52

Stuck in Sydney hotel, Astra CEO defended Covid vaccine and made mega deal

AstraZeneca announced Saturday it plans to buy rare-disease specialist Alexion Pharmaceuticals in a $39 billion deal

What a $32 million dinosaur can tell us about this year's art auctions

The sale of a $30 million sculpture cast 50 years ago might not tell you much about a $15,000 drawing made last month, but it could- and often does-give you some sense of where the winds are blowing

Facing trust deficit, Russian, Chinese vaccine could use a shot in the arm

For an indication of the trust deficit, look at the way the market responded to Russia's green light for its Sputnik V vaccine, or to news the flagship vaccine is more than 90% effective

Covid-19 vaccines raise hope for cancer, throw open new field of medicine

Approach used by Moderna. and Pfizer, BioNTech SE partnership have never been used outside of clinical experiments.

Investors look for long-term plan from Vedanta after $1 billion bond sale

Company's failure to simplify its corporate layout by delisting its Indian unit Vedanta Ltd. in Oct. had triggered concerns on its ability to refinance its debt maturities.